Verition Fund Management
SRNE

Verition Fund Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Verition Fund Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,971
Closed -$34K – 3050
2022
Q3 		$34K Hold
21,971
– – ﹤0.01% 2734
2022
Q2 		$44K Buy
+21,971
New +$38K ﹤0.01% 2161
2021
Q4 		– Sell
-10,922
Closed -$83K – 2926
2021
Q3 		$83K Sell
10,922
-447
-4% -$3.79K ﹤0.01% 1731
2021
Q2 		$110K Buy
+11,369
New +$90.5K ﹤0.01% 1712
2018
Q2 		– Sell
-23,602
Closed -$122K – 1405
2018
Q1 		$122K Buy
+23,602
New +$168K 0.01% 1046

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Verition Fund Management's SRNE Position: Q4 2022 in Review

Verition Fund Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 21,971 shares — an estimated $34K sold.

Verition Fund Management first reported a position in SRNE in Q1 2018 and held it in 5 quarters. The position peaked at $122K in Q1 2018. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

  • Verition Fund Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 21,971 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $34K.
  • Verition Fund Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2018 and held it in 5 quarters.
  • Verition Fund Management's Sorrento Therapeutics, Inc. position peaked at $122K in Q1 2018.
  • 221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.